Matches in Wikidata for { <http://www.wikidata.org/entity/Q39262037> ?p ?o ?g. }
- Q39262037 description "2011 nî lūn-bûn" @default.
- Q39262037 description "2011年の論文" @default.
- Q39262037 description "2011年学术文章" @default.
- Q39262037 description "2011年学术文章" @default.
- Q39262037 description "2011年学术文章" @default.
- Q39262037 description "2011年学术文章" @default.
- Q39262037 description "2011年学术文章" @default.
- Q39262037 description "2011年學術文章" @default.
- Q39262037 description "2011年學術文章" @default.
- Q39262037 description "2011年學術文章" @default.
- Q39262037 description "2011年學術文章" @default.
- Q39262037 description "2011年學術文章" @default.
- Q39262037 description "2011年學術文章" @default.
- Q39262037 description "2011년 논문" @default.
- Q39262037 description "article científic" @default.
- Q39262037 description "article scientific" @default.
- Q39262037 description "article scientifique (publié 2011)" @default.
- Q39262037 description "articol științific" @default.
- Q39262037 description "articolo scientifico" @default.
- Q39262037 description "artigo científico (publicado na 2011)" @default.
- Q39262037 description "artigo científico (publicado na 2011)" @default.
- Q39262037 description "artigo científico" @default.
- Q39262037 description "artikull shkencor" @default.
- Q39262037 description "artikulong pang-agham" @default.
- Q39262037 description "artykuł naukowy" @default.
- Q39262037 description "artículo científico publicado en 2011" @default.
- Q39262037 description "artículu científicu espublizáu en 2011" @default.
- Q39262037 description "bilimsel makale" @default.
- Q39262037 description "bài báo khoa học" @default.
- Q39262037 description "mokslinis straipsnis" @default.
- Q39262037 description "naučni članak" @default.
- Q39262037 description "scienca artikolo" @default.
- Q39262037 description "scientific article" @default.
- Q39262037 description "teaduslik artikkel" @default.
- Q39262037 description "tieteellinen artikkeli" @default.
- Q39262037 description "tudományos cikk" @default.
- Q39262037 description "vedecký článok" @default.
- Q39262037 description "vetenskaplig artikel" @default.
- Q39262037 description "videnskabelig artikel (udgivet 2011)" @default.
- Q39262037 description "vitenskapelig artikkel" @default.
- Q39262037 description "vitskapeleg artikkel" @default.
- Q39262037 description "vědecký článek" @default.
- Q39262037 description "wetenschappelijk artikel" @default.
- Q39262037 description "wissenschaftlicher Artikel" @default.
- Q39262037 description "επιστημονικό άρθρο" @default.
- Q39262037 description "мақолаи илмӣ" @default.
- Q39262037 description "мақолаи илмӣ" @default.
- Q39262037 description "наукова стаття, опублікована в липні 2011" @default.
- Q39262037 description "научна статия" @default.
- Q39262037 description "научная статья" @default.
- Q39262037 description "научни чланак" @default.
- Q39262037 description "научни чланак" @default.
- Q39262037 description "գիտական հոդված" @default.
- Q39262037 description "מאמר מדעי" @default.
- Q39262037 description "سائنسی مضمون" @default.
- Q39262037 description "مقالة علمية نشرت بتاريخ 25-7-2011" @default.
- Q39262037 description "مقالهٔ علمی" @default.
- Q39262037 description "২০১১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q39262037 description "บทความทางวิทยาศาสตร์" @default.
- Q39262037 description "სამეცნიერო სტატია" @default.
- Q39262037 name "Randomized phase II trial of Custirsen (OGX-011) in combination with docetaxel or mitoxantrone as second-line therapy in patients with metastatic castrate-resistant prostate cancer progressing after first-line docetaxel: CUOG trial P-06c." @default.
- Q39262037 name "Randomized phase II trial of Custirsen (OGX-011) in combination with docetaxel or mitoxantrone as second-line therapy in patients with metastatic castrate-resistant prostate cancer progressing after first-line docetaxel: CUOG trial P-06c." @default.
- Q39262037 name "Randomized phase II trial of Custirsen" @default.
- Q39262037 type Item @default.
- Q39262037 label "Randomized phase II trial of Custirsen (OGX-011) in combination with docetaxel or mitoxantrone as second-line therapy in patients with metastatic castrate-resistant prostate cancer progressing after first-line docetaxel: CUOG trial P-06c." @default.
- Q39262037 label "Randomized phase II trial of Custirsen (OGX-011) in combination with docetaxel or mitoxantrone as second-line therapy in patients with metastatic castrate-resistant prostate cancer progressing after first-line docetaxel: CUOG trial P-06c." @default.
- Q39262037 label "Randomized phase II trial of Custirsen" @default.
- Q39262037 prefLabel "Randomized phase II trial of Custirsen (OGX-011) in combination with docetaxel or mitoxantrone as second-line therapy in patients with metastatic castrate-resistant prostate cancer progressing after first-line docetaxel: CUOG trial P-06c." @default.
- Q39262037 prefLabel "Randomized phase II trial of Custirsen (OGX-011) in combination with docetaxel or mitoxantrone as second-line therapy in patients with metastatic castrate-resistant prostate cancer progressing after first-line docetaxel: CUOG trial P-06c." @default.
- Q39262037 prefLabel "Randomized phase II trial of Custirsen" @default.
- Q39262037 P1433 Q39262037-B87F862E-964F-451B-B011-765F0248FD28 @default.
- Q39262037 P1476 Q39262037-AAE09AC5-9606-44E4-AEBB-328C6D31E4D1 @default.
- Q39262037 P2093 Q39262037-04A5C412-BE24-4AC8-A2B0-9D545BFAB6B8 @default.
- Q39262037 P2093 Q39262037-0ED8621E-CD8A-46FB-A5D0-4D3452E6B5A5 @default.
- Q39262037 P2093 Q39262037-20F3FFCA-0003-429C-A04C-AB36A7306173 @default.
- Q39262037 P2093 Q39262037-34B928B3-0E75-4F26-BCF1-8F404D0A5C8F @default.
- Q39262037 P2093 Q39262037-446BDF18-0473-40ED-A0DA-04BD3D95CC5A @default.
- Q39262037 P2093 Q39262037-709197E7-98C7-43B1-BBF7-B86A3668C38F @default.
- Q39262037 P2093 Q39262037-789AA081-5F8D-47D7-A609-1CE19DDB2E22 @default.
- Q39262037 P2093 Q39262037-7A393C07-6405-4A10-BADB-529C4D20E5DA @default.
- Q39262037 P2093 Q39262037-891FA75C-7C05-4A4E-BDF5-C68368DF4E18 @default.
- Q39262037 P2093 Q39262037-B424F7F6-ED3E-4795-AB79-67CF659274DC @default.
- Q39262037 P2093 Q39262037-C3319F51-7E01-4379-B840-FF721B8EE75E @default.
- Q39262037 P2093 Q39262037-D475CA56-E3CA-4CB3-9B2F-15139F9B20F3 @default.
- Q39262037 P304 Q39262037-FE5893DE-81DD-44D9-951F-95EDB28E93BD @default.
- Q39262037 P31 Q39262037-F78949C7-9E5B-4F2F-ADF2-37B91E95F1AC @default.
- Q39262037 P356 Q39262037-84530BC8-532A-4C90-A9FD-4C4E83D470A0 @default.
- Q39262037 P407 Q39262037-20E008D7-C110-4823-937F-7D4665AE136F @default.
- Q39262037 P433 Q39262037-5BD8B0EA-C1B9-4900-8667-7F36F3AB91B9 @default.
- Q39262037 P478 Q39262037-C85C98D1-6EC9-47EC-93AB-AEE99704D7D6 @default.
- Q39262037 P50 Q39262037-0B44D2F3-90A5-423C-8607-139FF93F0AAD @default.
- Q39262037 P50 Q39262037-CF5BE5A1-B659-40B6-9BB7-B6C5EEF891B7 @default.
- Q39262037 P577 Q39262037-6D76AE68-3078-407B-8992-575FA6480A4A @default.
- Q39262037 P698 Q39262037-006A3853-29A2-4586-B58C-E3F8114A81D0 @default.
- Q39262037 P921 Q39262037-0D9991EF-52FE-45CC-A45F-5B527312CD27 @default.
- Q39262037 P921 Q39262037-46A3D88A-FBFF-4E22-9341-6E562CF6F143 @default.
- Q39262037 P921 Q39262037-47E993B6-5368-44A3-8593-ED1342870B3D @default.
- Q39262037 P356 1078-0432.CCR-11-0859 @default.
- Q39262037 P698 21788353 @default.
- Q39262037 P1433 Q332253 @default.